Business Context and Reporting Period
This Form 8-K is a current report filed by Trxade Group, Inc. (noting a discrepancy with the request metadata which listed "Scienture Holdings, Inc.") on June 25, 2020. The company is incorporated in Delaware, trades on the NASDAQ Capital Market under the symbol MEDS, and is classified as an emerging growth company. The report details unregistered equity sales and the execution of a new executive employment agreement.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. Specific financial data disclosed includes:
- Capital Raised: $20,100 received from the exercise of warrants.
- Executive Compensation: Annual salary of $120,000 for the Chief Financial Officer.
Material Changes and Corporate Actions
Unregistered Sales of Equity Securities (Item 3.02)
On June 25, 2020, Gajan Mahendiran, a greater than 5% beneficial owner, exercised warrants to purchase 335,002 shares of common stock at an exercise price of $0.06 per share. The company received the aggregate payment of $20,100. The issuance was made pursuant to an exemption from registration under Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act of 1933.
Executive Employment Agreement (Item 5.02)
The company entered into an Executive Employment Agreement with Howard A. Doss, effective June 19, 2020, for his role as Chief Financial Officer. Key terms include:
- Compensation: $120,000 annual salary plus eligibility for discretionary bonuses.
- Termination: Employment is "at-will" with a requirement for 30 days' prior written notice.
- Restrictions: Includes 12-month non-compete and non-solicitation prohibitions following termination.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond standard legal disclosures regarding the unregistered securities. The securities issued to Mr. Mahendiran are subject to transfer restrictions and may not be offered or sold absent registration or an exemption.
Investor Verification Checklist
- Verify the correct registrant name (Trxade Group, Inc. vs. Scientificure Holdings, Inc.) and ticker symbol (MEDS).
- Confirm the impact of the 335,002 new shares on total outstanding share count and potential dilution.
- Review the attached Exhibit 10.1 for the full text of the CFO's employment agreement and bonus criteria.
- Check subsequent filings for the official issuance of the restricted stock certificates to Mr. Mahendiran.